Actinium Pharmaceuticals, Inc. (ATNM)
1.11
-0.03
(-2.63%)
USD |
NYAM |
Mar 03, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Research and Development Expense (Annual) : 29.88M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Assertio Holdings, Inc. | 3.822M |
| Altimmune, Inc. | 81.99M |
| Aldeyra Therapeutics, Inc. | 25.66M |
| Avanos Medical, Inc. | 22.60M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |